Date: 25-Sep-2019

Parexel expands Ph I research capabilities in China

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization, announced it has formed alliances with three prominent healthcare institutions ─ PKUCare Luzhong Hospital, West China Medical Center, and Shanghai Xuhui Central Hospital ─ providing an enhanced level of support for customers conducting Phase I studies in China.